AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Pomerantz investigates Nutex Health for securities fraud allegations.
ByAinvest
Saturday, Aug 9, 2025 11:57 am ET1min read
Pomerantz LLP is investigating claims of securities fraud against Nutex Health Inc. (NASDAQ: NUTX). The investigation concerns Nutex's relationship with HaloMD, a third-party vendor recently sued for allegedly engaging in a fraudulent scheme. Following a short report by Blue Orca Capital, Nutex's stock price fell 10.05%. Investors who purchased NUTX stock are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Nutex Health Inc. (NASDAQ: NUTX) is facing a securities fraud investigation by Pomerantz LLP, a prominent law firm specializing in corporate, securities, and antitrust class litigation. The investigation centers around Nutex's relationship with HaloMD, a third-party vendor that has recently been the subject of lawsuits alleging fraudulent schemes.The investigation was prompted by a critical report issued by Blue Orca Capital on July 22, 2025, which alleged that Nutex's use of HaloMD as an independent dispute resolution (IDR) vendor may have led to misleading disclosures and improper revenue recognition. The report also noted that Nutex's stock price fell by 10.05% on July 22, 2025, closing at $100.01 per share, following the publication of the report [2].
Nutex's use of HaloMD and its impact on the company's financial statements have come under scrutiny. The No Surprises Act (NSA), implemented in 2022, has had a significant impact on Nutex's revenue, leading to substantial operating and net losses in 2022 and 2023. Nutex's market capitalization has plummeted to less than $30 million as a result [3].
Investors who purchased Nutex stock and believe they have suffered substantial losses are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980, to participate in the investigation or learn more about the claims [2].
References:
[1] https://www.morningstar.com/news/business-wire/20250808663025/securities-fraud-investigation-into-marex-group-plc-mrx-announced-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-a-leading-securities-fraud-law-firm
[2] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nutex-health-inc---nutx-302521624.html
[3] https://www.morningstar.com/news/globe-newswire/9506826/nutex-health-nutx-shares-fall-amid-critical-blue-orca-report-hagens-berman
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet